KIM DONG YEON,김동연,SHIN JAE SOO,신재수,CHO DAE JIN,조대진,LEE GONG YEAL,이공열,KIM HONG YOUB,김홍엽,LEE HEA UN,이해언,AHN CHOONG AM,안충암,SONG SONG EI,송송이,PARK JONG SEONG,박종성,KANG SOUNG YOUNG,강성영,KIM YONG SUN,김용선,CHOI,최은경,최영곤,박정호
申请号：
KR1020180078887
公开号：
KR1020200005314A
申请日:
2018.07.06
申请国别(地区):
KR
年份:
2020
代理人:
摘要：
The present invention relates to a pharmaceutical composition for preventing or treating prion disease, which is one of neurodegenerative diseases, wherein the pharmaceutical composition contains radotinib or pharmaceutically acceptable salt thereof as an active component. Radotinib or the pharmaceutically acceptable salt thereof, which is the active component of the pharmaceutical composition of the present invention exhibits an effect of inhibiting the deposition formation of pathogenic prions.COPYRIGHT KIPO 2020본 발명은 라도티닙(Radotinib) 또는 그의 약제학적으로 허용 가능한 염을 유효성분으로 포함하는, 신경퇴행성 질환중의 하나인 프리온 질환의 예방 또는 치료를 위한 약제학적 조성물에 관한 것이다.
